Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer’s Disease

Overview of attention for article published in PLOS ONE, July 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news: 1 news outlet
twitter: 6 X users
patent: 1 patent

peer_reviews: 1 peer review site
reddit: 1 Redditor

Readers on

mendeley: 71 Mendeley

Summary News X Patents Peer reviews Reddit

So far, Altmetric has seen 1 peer review sites that discuss this research output.

PubPeer

This paper has 3 comments on PubPeer, an open scientific commentary website.

Comment from PubMed Commons

16 Aug 2016

Niels Vrang | Aug 16 2016 06:06 ESTWe welcome discussion and critique although we do not approve of the rather broad spectrum of points raised in this comment...

Niels Vrang

11 Aug 2016

We welcome discussion and critique although we do not approve of the rather broad spectrum of points raised in this comment. We do stand by our results which have been generated by several skilled…

Comment from PubMed Commons

08 Aug 2016

Christian Holscher | Aug 08 2016 12:09 ESTThis is a misleading and unscientific paper. The authors measure amyloid plaque load in a London mutation APP mouse model which does not develop amyloid…

This page shows the most recent peer reviews that mention this research output.

Click here to find out how to access more activity.